000			02151 a2200589 4500
005			20250517171418.0
264		0	_c20190111
008			201901s 0 0 eng d
022			_a1029-2403
024	7		_a10.1080/10428194.2017.1366998 _2doi
040			_aNLM _beng _cNLM
100	1		_aSanchez-Garcia, Joaquin
245	0	0	_aProspective randomized trial of 5 days azacitidine versus supportive care in patients with lower-risk myelodysplastic syndromes without 5q deletion and transfusion-dependent anemia. _h[electronic resource]
260			_bLeukemia & lymphoma _c05 2018
300			_a1095-1104 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAnemia _xepidemiology
650	0	4	_aAntimetabolites, Antineoplastic _xtherapeutic use
650	0	4	_aAzacitidine _xtherapeutic use
650	0	4	_aBlood Transfusion _xmethods
650	0	4	_aChromosome Deletion
650	0	4	_aChromosomes, Human, Pair 5 _xgenetics
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMyelodysplastic Syndromes _xgenetics
650	0	4	_aPalliative Care
650	0	4	_aPrognosis
650	0	4	_aProspective Studies
650	0	4	_aSurvival Rate
700	1		_aFalantes, Jose
700	1		_aMedina Perez, Angeles
700	1		_aHernandez-Mohedo, Francisca
700	1		_aHermosin, Lourdes
700	1		_aTorres-Sabariego, Angeles
700	1		_aBailen, Alicia
700	1		_aHernandez-Sanchez, Jesus M
700	1		_aSolé Rodriguez, María
700	1		_aCasaño, Francisco Javier
700	1		_aCalderon, Cristina
700	1		_aLabrador, Maria
700	1		_aVahí, Maria
700	1		_aSerrano, Josefina
700	1		_aLumbreras, Eva
700	1		_aHernández-Rivas, Jesus Maria
773	0		_tLeukemia & lymphoma _gvol. 59 _gno. 5 _gp. 1095-1104
856	4	0	_uhttps://doi.org/10.1080/10428194.2017.1366998 _zAvailable from publisher's website
999			_c27493779 _d27493779